Attach 6 DARF Working Group

Attach_6_DARF Working Group.doc

Investigator Registration and Financial Disclosure for Investigational Trials in Cancer Treatment (NCI)

Attach 6 DARF Working Group

OMB: 0925-0613

Document [doc]
Download: doc | pdf

Attachment 6: DARF Working Group



Investigator: Stephen Schimpff, M.D.

Pharmacist: Mr. William Grove

University of Maryland Cancer Center

22 S. Greene Street

Baltimore, Maryland 21201

(410) 328‑7606



Investigator: Joseph Simone, M.D.

Pharmacist: Mr. Raymond Mueller

Memorial Sloan‑Kettering Cancer Center

1275 New York Ave

New York, NY 10021

(212) 639‑5842


Investigator: Robert Warren, M.D.

Nurse: Ms. Faith Jodoin

5226 Dawes Avenue

Alexandria, Virginia 22311

(703) 379‑9111


Investigator: Ray Warrell, M.D.

Pharmacist: Mr. Raymond Mueller

Memorial Sloan‑Kettering Cancer Center

1275 York Avenue

New York, New York 10021

(212) 794‑7615



Investigator: James Holland, M.D.

Pharmacist: Mr. Robert Frank

Mt. Sinai Hospital

1 Gustave L. Levy Place

New York, New York 10029

(212) 41‑6361



Investigator: Philip Schein, M.D.

U.S. Bioscience, Inc.

One Tower Bridge, Ste 400

West Conshohockem, PA 19428

(215) 832‑4501


Investigator: Emil Frei, M.D.

Pharmacist: Dr. Steve Steckel

Dana Farber Cancer Center

44 Binney Street

Boston, Massachusetts 02115

(617) 632‑3555








File Typeapplication/msword
AuthorVivian Horovitch-Kelley
Last Modified ByHall, Charles (NIH/NCI) [E]
File Modified2015-09-11
File Created2015-09-11

© 2024 OMB.report | Privacy Policy